Iris Dorbian
Cambridge, Massachusetts-based Black Diamond Therapeutics, Inc., a precision oncology medicine company, has raised $85 million in Series C financing.
Kaiser Permanente Ventures has closed its fifth fund at $141 million.
Richmond, Virginia-based Nutriati, a maker of plant-based ingredients, has raised $12.7 million in Series C funding.
Ogury, a creator of a digital marketing engine, has raised $50 million in funding.
Philadelphia and Cambridge, Massachusetts-based Limelight Bio, a biopharmaceutical company developing novel gene therapies, has raised $75 million in financing.
Akoya Biosciences Inc, a spatial biology company, has secured $50 million in funding.
San Francisco Bay Area-based Vertosa, a cannabis technology company, has secured $6 million in funding.
Tel Aviv-based Crescendo Venture Partners is seeking to raise between $80 million and $100 million for its new venture fund.
Postscript, a marketing tech platform, has raised $4.5 million in funding.
Advanced Navigation, an Australian robotics and AI sensor business, has raised $20 million in Series A funding.